105 related articles for article (PubMed ID: 23174883)
61. Biological research on the occurrence and development of multiple myeloma and its treatment.
Wu Y; Shi X; Yao X; Du X
Immun Inflamm Dis; 2023 May; 11(5):e850. PubMed ID: 37249283
[TBL] [Abstract][Full Text] [Related]
62. Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets.
Arif KMT; Elliott EK; Haupt LM; Griffiths LR
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050637
[TBL] [Abstract][Full Text] [Related]
63.
Li B; Liu C; Cheng G; Peng M; Qin X; Liu Y; Li Y; Qin D
J Cancer; 2019; 10(3):577-582. PubMed ID: 30719154
[TBL] [Abstract][Full Text] [Related]
64. miR-24-3p/FGFR3 Signaling as a Novel Axis Is Involved in Epithelial-Mesenchymal Transition and Regulates Lung Adenocarcinoma Progression.
Jing P; Zhao N; Xie N; Ye M; Zhang Y; Zhang Z; Li M; Lai X; Zhang J; Gu Z
J Immunol Res; 2018; 2018():2834109. PubMed ID: 29850625
[TBL] [Abstract][Full Text] [Related]
65. The therapeutic potential of cell cycle targeting in multiple myeloma.
Maes A; Menu E; Veirman K; Maes K; Vand Erkerken K; De Bruyne E
Oncotarget; 2017 Oct; 8(52):90501-90520. PubMed ID: 29163849
[TBL] [Abstract][Full Text] [Related]
66. Expression of the miR-148/152 Family in Acute Myeloid Leukemia and its Clinical Significance.
Wang XX; Zhang R; Li Y
Med Sci Monit; 2017 Oct; 23():4768-4778. PubMed ID: 28978904
[TBL] [Abstract][Full Text] [Related]
67. Identification of key genes and construction of microRNA-mRNA regulatory networks in multiple myeloma by integrated multiple GEO datasets using bioinformatics analysis.
Gao H; Wang H; Yang W
Int J Hematol; 2017 Jul; 106(1):99-107. PubMed ID: 28316065
[TBL] [Abstract][Full Text] [Related]
68. Polydatin protects the respiratory system from PM
Yan XD; Wang QM; Tie C; Jin HT; Han YX; Zhang JL; Yu XM; Hou Q; Zhang PP; Wang AP; Zhang PC; Gao Z; Jiang JD
Sci Rep; 2017 Jan; 7():40030. PubMed ID: 28067267
[TBL] [Abstract][Full Text] [Related]
69. Downregulation of MicroRNA-152 contributes to high expression of DKK1 in multiple myeloma.
Xu Y; Chen B; George SK; Liu B
RNA Biol; 2015; 12(12):1314-22. PubMed ID: 26400224
[TBL] [Abstract][Full Text] [Related]
70. miRGate: a curated database of human, mouse and rat miRNA-mRNA targets.
Andrés-León E; González Peña D; Gómez-López G; Pisano DG
Database (Oxford); 2015; 2015():bav035. PubMed ID: 25858286
[TBL] [Abstract][Full Text] [Related]
71. Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases.
Katoh M
Front Cell Dev Biol; 2014; 2():61. PubMed ID: 25364765
[TBL] [Abstract][Full Text] [Related]
72. Global epigenetic regulation of microRNAs in multiple myeloma.
Zhang W; Wang YE; Zhang Y; Leleu X; Reagan M; Zhang Y; Mishima Y; Glavey S; Manier S; Sacco A; Jiang B; Roccaro AM; Ghobrial IM
PLoS One; 2014; 9(10):e110973. PubMed ID: 25330074
[TBL] [Abstract][Full Text] [Related]
73. Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.
Fleming NH; Zhong J; da Silva IP; Vega-Saenz de Miera E; Brady B; Han SW; Hanniford D; Wang J; Shapiro RL; Hernando E; Osman I
Cancer; 2015 Jan; 121(1):51-9. PubMed ID: 25155861
[TBL] [Abstract][Full Text] [Related]
74. MicroRNA: important player in the pathobiology of multiple myeloma.
Bi C; Chng WJ
Biomed Res Int; 2014; 2014():521586. PubMed ID: 24991558
[TBL] [Abstract][Full Text] [Related]
75. Epigenetic regulation of thyroid hormone receptor beta in renal cancer.
Wojcicka A; Piekielko-Witkowska A; Kedzierska H; Rybicka B; Poplawski P; Boguslawska J; Master A; Nauman A
PLoS One; 2014; 9(5):e97624. PubMed ID: 24849932
[TBL] [Abstract][Full Text] [Related]
76. Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma.
Saki N; Abroun S; Hajizamani S; Rahim F; Shahjahani M
Cell J; 2014; 16(2):99-110. PubMed ID: 24567933
[TBL] [Abstract][Full Text] [Related]
77. Staging and prognostication of multiple myeloma.
Fonseca R; Monge J; Dimopoulos MA
Expert Rev Hematol; 2014 Feb; 7(1):21-31. PubMed ID: 24483346
[TBL] [Abstract][Full Text] [Related]
78. Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.
Abdi J; Chen G; Chang H
Oncotarget; 2013 Dec; 4(12):2186-207. PubMed ID: 24327604
[TBL] [Abstract][Full Text] [Related]
79. DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment.
Gourzones-Dmitriev C; Kassambara A; Sahota S; Rème T; Moreaux J; Bourquard P; Hose D; Pasero P; Constantinou A; Klein B
Cell Cycle; 2013 Sep; 12(17):2760-73. PubMed ID: 23966156
[TBL] [Abstract][Full Text] [Related]
80. Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors.
Moreaux J; Reme T; Leonard W; Veyrune JL; Requirand G; Goldschmidt H; Hose D; Klein B
Br J Cancer; 2013 Aug; 109(3):676-85. PubMed ID: 23868005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
